GIP and diabetes mellitus: It will be important to identify the neurotransmitters or neuropeptides that mediate the effects of Xen on insulin and glucagon release in humans because signaling pathways initiated by Xen rather than GIP fail early during the development of type 2 diabetes mellitus.